Skip to main content

Advertisement

SpringerLink
Log in

Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kwong YL (2014) Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides. Ann Hematol 93(4):713–714

    Article  PubMed  Google Scholar 

  2. Hwang YY, Cheung WW, Leung AY, Tse E, Au WY, Kwong YL (2009) Valganciclovir thrice weekly for prophylaxis against cytomegalovirus reactivation during alemtuzumab therapy. Leukemia 23(4):800–801

    Article  CAS  PubMed  Google Scholar 

  3. Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL (2012) Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leuk Lymphoma 53(8):1515–1524

    Article  CAS  PubMed  Google Scholar 

  4. Seto WK, Wong DH, Chan TY, Hwang YY, Fung J, Liu KS, Gill H, Lam YF, Cheung KS, Lie AK, Lai CL, Kwong YL, Yuen MF (2016) Association of hepatitis B core-related antigen with hepatitis B virus reactivation in occult viral carriers undergoing high-risk immunosuppressive therapy. Am J Gastroenterol 111(12):1788–1795

    Article  CAS  PubMed  Google Scholar 

  5. Brown DN, Wieser I, Wang C, Dabaja BS, Duvic M (2015) Leonine facies (LF) and mycosis fungoides (MF): a single-center study and systematic review of the literature. J Am Acad Dermatol 73(6):976–986

    Article  PubMed  Google Scholar 

  6. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S, ISCL/EORTC (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110(6):1713–1722

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Pamela Youde Eastern Hospital, Hong Kong, China

    Bonnie Kho & Howard H. N. Wong

  2. Department of Pathology, Pamela Youde Eastern Hospital, Hong Kong, China

    Chun-Fung Sin

  3. Department of Pathology, Queen Mary Hospital, Hong Kong, China

    Rock Y. Y. Leung

  4. Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China

    Yok-Lam Kwong

Authors
  1. Bonnie Kho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Howard H. N. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun-Fung Sin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rock Y. Y. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yok-Lam Kwong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yok-Lam Kwong.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kho, B., Wong, H.H.N., Sin, CF. et al. Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab. Ann Hematol 96, 2121–2123 (2017). https://doi.org/10.1007/s00277-017-3113-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3113-8

Search

Navigation